InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
40,000
$1.29
$51.60K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$7.89
$78.90K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.00
$30.00K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.46
$34.60K
Stephen Basil Thomas
15 Sep 2026
Director
Sold on a plan
100,000
$13.67
$1.37M
Aoife Brennan
29 Jun 2026
President and CEO
Sold on a plan
30,902
$13.17
$406.98K
Stephen Basil Thomas
26 Feb 2026
Director
Sold on a plan
16,313
$7.01
$114.29K
Stephen Basil Thomas
25 Feb 2026
Director
Sold on a plan
33,687
$7.00
$235.96K
Stephen Basil Thomas
13 Feb 2026
Director
Sold on a plan
10,000
$5.81
$58.14K
Stephen Basil Thomas
12 Feb 2026
Director
Sold on a plan
90,000
$5.23
$470.99K
Ra Capital Management, L.p.
5 Jan 2026
Director
Buy indirect
7,111
$3.50
$24.89K
Ra Capital Management, L.p.
12 Dec 2025
Director
Buy indirect
101,462
$2.86
$290.18K
Ra Capital Management, L.p.
11 Dec 2025
Director
Buy indirect
213,099
$2.18
$464.56K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 20,578,750
History held since 11 Aug 2021